Atlas Trials

Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma

Clinical trial NCT01020812 · TERMINATED

Trial details

NCT number
NCT01020812
Sponsor
Stanford University
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Carcinoma, HepatocellularHepatobiliary NeoplasmLiver Carcinoma
Start date
2009-09-01
Primary completion
2014-03-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.